Open access
1,994
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks
Marco Galluzzoa Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy;b Dermatology Unit, Fondazione Policlinico “Tor Vergata”, Rome, ItalyCorrespondence[email protected]
https://orcid.org/0000-0002-3424-5175View further author information
Lorenzo Marcellia Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy;b Dermatology Unit, Fondazione Policlinico “Tor Vergata”, Rome, ItalyView further author information
, Laura Velluccia Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy;b Dermatology Unit, Fondazione Policlinico “Tor Vergata”, Rome, ItalyView further author information
, Claudia Paganinia Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy;b Dermatology Unit, Fondazione Policlinico “Tor Vergata”, Rome, ItalyView further author information
, Virginia Maffeia Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy;b Dermatology Unit, Fondazione Policlinico “Tor Vergata”, Rome, ItalyView further author information
, Lorenzo Tofania Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy;b Dermatology Unit, Fondazione Policlinico “Tor Vergata”, Rome, ItalyView further author information
, Alfredo Belcastroc School of Medicine and Surgery, University of Rome “Tor Vergata”, Rome, ItalyView further author information
, Luca Bianchia Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy;b Dermatology Unit, Fondazione Policlinico “Tor Vergata”, Rome, Italy
https://orcid.org/0000-0001-8697-6896View further author information
Marina Talamontib Dermatology Unit, Fondazione Policlinico “Tor Vergata”, Rome, Italy
https://orcid.org/0000-0002-3070-4071View further author information
Pages 371-381
|
Received 18 Jan 2023, Accepted 20 Mar 2023, Published online: 27 Mar 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.